GlassScriptPhysician profile
Haris Khan
NPI 1518595933
$3,145.12
in general payments reported to CMS, 2019-2025
12 companies · $639 in 2025
The $639 reported for 2025 was more than what 83% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $235 · 2022: $1,381 · 2023: $512 · 2024: $378 · 2025: $639.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,003 · Travel and Lodging: $468 · Education: $58.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,002.81 |
| Travel and Lodging | $468.20 |
| Education | $58.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medwest Associates | $1,234.16 | 2022-2023 | |
| Stryker Corporation | $839.08 | 2023-2025 | Prostep, Actishield Cf, Hoffmann |
| Smith+Nephew, INC. | $197.93 | 2021-2025 | Collagenase Santyl, Panta 2, Renasys Go V2 Home |
| Integra Lifesciences Corporation | $161.87 | 2022 | |
| Convatec INC. | $149.93 | 2025 | |
| Linvatec Corporation | $139.92 | 2024 | Biobrace 23mm |
| Mimedx Group, INC. | $119.45 | 2024-2025 | |
| Horizon Therapeutics Plc | $110.71 | 2021 | |
| Paragon 28, INC. | $81.89 | 2025 | Precision Mis Bunion, Bun-Yo-Matic |
| Treace Medical Concepts, INC. | $55.19 | 2025 | |
| Amgen INC. | $35.13 | 2024-2025 | Krystexxa |
| Vertex Pharmaceuticals Incorporated | $19.86 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Haris Khan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.